Coldstream Capital Management Inc. lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 27,382 shares of the healthcare conglomerate's stock after buying an additional 660 shares during the period. Coldstream Capital Management Inc.'s holdings in UnitedHealth Group were worth $13,852,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of the business. Sugarloaf Wealth Management LLC boosted its position in UnitedHealth Group by 17.6% during the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after acquiring an additional 1,193 shares during the period. Signal Advisors Wealth LLC lifted its position in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock worth $4,611,000 after purchasing an additional 1,051 shares during the period. Waycross Partners LLC raised its stake in shares of UnitedHealth Group by 2.4% in the 4th quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate's stock worth $14,060,000 after buying an additional 658 shares in the last quarter. Czech National Bank boosted its stake in UnitedHealth Group by 6.1% during the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate's stock valued at $100,937,000 after buying an additional 11,426 shares in the last quarter. Finally, Lmcg Investments LLC lifted its holdings in UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate's stock valued at $19,210,000 after acquiring an additional 4,022 shares during the last quarter. Institutional investors own 87.86% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have issued reports on UNH shares. Cantor Fitzgerald restated an "overweight" rating and issued a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler decreased their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Raymond James reiterated a "strong-buy" rating and set a $540.00 price objective (down from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a report on Tuesday, January 28th. Finally, Barclays lowered their target price on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Three research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Buy" and an average price target of $603.05.
View Our Latest Stock Report on UNH
UnitedHealth Group Trading Up 0.3 %
NYSE UNH traded up $1.40 on Monday, reaching $420.04. The company had a trading volume of 6,598,014 shares, compared to its average volume of 4,490,735. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The stock has a market cap of $382.33 billion, a price-to-earnings ratio of 27.10, a PEG ratio of 1.37 and a beta of 0.61. The stock's 50 day moving average is $503.28 and its 200-day moving average is $534.18. UnitedHealth Group Incorporated has a 52 week low of $412.02 and a 52 week high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. During the same period in the prior year, the business earned $6.91 earnings per share. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.00%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is currently 35.18%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.